0001225208-20-011914.txt : 20200930
0001225208-20-011914.hdr.sgml : 20200930
20200930211038
ACCESSION NUMBER: 0001225208-20-011914
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20200930
DATE AS OF CHANGE: 20200930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39562
FILM NUMBER: 201214049
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulmonx Corp
CENTRAL INDEX KEY: 0001127537
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 700 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-364-0400
MAIL ADDRESS:
STREET 1: 700 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: PULMONX
DATE OF NAME CHANGE: 20001031
3
1
doc3.xml
X0206
3
2020-09-30
0
0001127537
Pulmonx Corp
LUNG
0000885725
BOSTON SCIENTIFIC CORP
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
Common Stock
141.0000
D
Series A-1 Preferred Stock
Common Stock
40705.0000
D
Series B-1 Preferred Stock
Common Stock
47536.0000
D
Series C-1 Preferred Stock
Common Stock
23180.0000
D
Series D-1 Preferred Stock
Common Stock
542.0000
D
Series E-1 Preferred Stock
Common Stock
6215.0000
D
Series F-1 Preferred Stock
Common Stock
3787878.0000
D
Series G-1 Preferred Stock
Common Stock
2081909.0000
D
Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
/s/ Vance R. Brown Vice President and Chief Corporate Counsel
2020-09-30